What should traders watch in the 1833.HK stock earnings report?

Traders should watch revenue growth, active user trends, online consultation volumes, gross margin movement, and management guidance. A surprise on monetisation or margin recovery will likely drive intraday volatility for 1833.HK stock.

How does Meyka AI value 1833.HK stock and what is the grade?

Meyka AI rates 1833.HK with a score out of 100 at **70.32**, grade **B+** with a BUY suggestion. The grade blends benchmark and sector comparisons, growth, key metrics and analyst views. This is informational, not financial advice.

What is the Meyka AI forecast for 1833.HK stock price?

Meyka AI's forecast model projects a yearly target of **HKD 21.99** and a quarterly level of **HKD 18.56** versus the current **HKD 13.91**. Forecasts are model-based projections and not guarantees.

Are there technical signals for intraday trading of 1833.HK stock?

Short-term technicals show **RSI 37.14** and MACD histogram **-0.08**, with ATR **HKD 0.56**. Low relative volume today suggests limited follow-through until the earnings release for 1833.HK stock.

HK Stocks

HKD 13.91: Ping An Healthcare 1833.HK HKSE ahead of 24 Feb earnings: analyst range

ByDanny Kontos February 19, 2026February 19, 2026

1833.HK stock trades at HKD 13.91 intraday in Hong Kong on 19 Feb 2026, with volume at 1,375,492 ahead of an earnings release scheduled for 24 Feb 2026. Investors will watch revenue and margin details after a year-high of HKD 24.40 and a year-low of HKD 6.06. Key metrics show EPS HKD 0.10 and a trailing PE of 139.10, which connects valuation to near-term earnings risk. This earnings spotlight reviews the numbers, analyst context, and what the Meyka AI forecast implies for intraday trading and the coming report.